Benjamin Damien
CEO, Sagitta Biotech
Benjamin has a PhD in Immunology and a MBA from Solvay Business School. He is working on vaccines for close to 30years, 23 of them in the industry as CEO, CSO or director. In the last few years he participated to the creation of 15 startups, and to the raise of over 30Million€.
Events Benjamin Damien has spoken at
- BioTrinity 2026 14 April 2026 – 15 April 2026